This study is a no brainer. I love the following quote:
“As a surgeon, you often ask yourself are we really repairing the valve or are we just delaying the next heart valve operation or replacement. Where most patients with symptomatic aortic valve disease will be delayed to surgery, this study could prove that CardioCel could offer earlier intervention, with possible life-long benefits,” said Domenico Mazzitelli, cardiac surgeon and clinical study lead at the German Heart Centre Munich.
World Leading Product (Cardiocell) , Yes a big cash spend, possible further CRs, but therein lies the Great Opportunity as Investors in AHZ!!!
The Hoover is plugged in & i'm ready to suck up as many shares as possible in AHZ.
Waiting, Watching, Grinning,
Pandelis
- Forums
- ASX - By Stock
- Ann: Admedus initiates heart valve clinical study
This study is a no brainer. I love the following quote: “As a...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M |
Open | High | Low | Value | Volume |
$18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.00 | 499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30 | 17.720 |
1 | 793 | 17.660 |
1 | 39 | 17.650 |
3 | 1007 | 17.550 |
1 | 1 | 17.510 |
Price($) | Vol. | No. |
---|---|---|
18.000 | 499 | 1 |
18.050 | 550 | 1 |
18.300 | 313 | 2 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |